Immunomedics submits LeukoScan to FDA

Article

Immunomedics of Morris Plains, NJ, has submitted a biologies licenseapplication to the Food and Drug Administration for approval ofLeukoScan, a technetium-99m-labeled monoclonal antibody-basedagent for imaging bone infection. LeukoScan received a

Immunomedics of Morris Plains, NJ, has submitted a biologies license

application to the Food and Drug Administration for approval of

LeukoScan, a technetium-99m-labeled monoclonal antibody-based

agent for imaging bone infection. LeukoScan received a positive

recommendation from Europe's Committee for Proprietary Medicinal

Products in October (SCAN 10/23/96).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Leading Breast Radiologists Discuss Rise of Breast Cancer Incidence in Women Under 40
New Research Examines Radiation Risks with CT Exposure Prior to Pregnancy
Diagnostic Imaging’s Weekly Scan: August 31 — September 6
© 2025 MJH Life Sciences

All rights reserved.